Literature DB >> 18932025

[The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].

Sule Karadayi1, Ayten Kayi Cangir, Sibel Ozturk, Serpil Dizbay Sak, Murat Akal, Hadi Akay.   

Abstract

Lung cancer is the most common type of cancer among males and females in developed countries. Currently, the five-year survival rate of lung cancer patients is 14%. Immune system has been considered to play an important role in the development and metastasis of lung cancer. In this study, natural killer (NK) cell infiltration was evaluated in the tumor tissues of 40 patients with stage I non-small cell lung cancer (NSCLC) to evaluate its effect on the prognosis. The evaluation included the tissue samples of 40 patients who underwent resection due to NSCLC between 1994 and 1998 in Ankara University Medical School, Chest Surgery Department. All the patients had stage I squamous cell carcinoma. The patients were followed-up for 4-8 years postoperatively. NK cell counts varied between 1 and 86 (mean: 13.63 +/- 11.86). The patients were divided into two groups according to their cell counts as low (n= 24) and high (n= 16). The mean survival time of the group with low NK cell count was 52 +/- 6 months and the mean five-year survival rate was 51%. The mean survival time of the group with high NK cell count was 58 +/- 4 months and the mean five-year survival rate was 68%. No statistically significant difference was detected between the two groups for five-year survival time (p= 0.15). As a result, in our study we did not find any significant effect of natural killer infiltration on tumoral tissue in prognosis of stage I NSCLC.

Entities:  

Mesh:

Year:  2008        PMID: 18932025

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  2 in total

1.  Does hydatid disease have protective effects against lung cancer?

Authors:  Sule Karadayi; Sulhattin Arslan; Zeynep Sumer; Mustafa Turan; Haldun Sumer; Kursat Karadayi
Journal:  Mol Biol Rep       Date:  2013-05-05       Impact factor: 2.316

2.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.